Apotex Equate Maximum Strength Ranitidine Tablets Recall: Possible NDMA Contamination
Apotex recalls 150mg ranitidine tablets due to possible N-nitrosodimethylamine (NDMA) contamination. Consumers should check NDC numbers and contact Apotex for details.
Recall notice
GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA).
Contact the company
What happened, in plain English
Apotex is recalling 150mg ranit: a common acid reducer that may contain harmful impurities. This could pose health risks if taken regularly, so affected users should stop using and contact Apotex. Read more at govinfonow.com/recall/37904-apotex-equate-maximum-strength-ranitidine-tablets-recall-possible-ndma-contamination.
Source Summary by GovInfoNow · govinfonow.com/recall/37904-apotex-equate-maximum-strength-ranitidine-tablets-recall-possible-ndma-contamination · Updated October 5, 2026 · FDA enforcement record: FDA #D-0316-2020
Cite this page
“Apotex Equate Maximum Strength Ranitidine Tablets Recall: Possible NDMA Contamination.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37904-apotex-equate-maximum-strength-ranitidine-tablets-recall-possible-ndma-contamination. Based on FDA recall #D-0316-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0316-2020%22&limit=1).
Why it’s dangerous
The tablets may contain N-nitrosodimethylamine (NDMA), a harmful impurity linked to cancer risk. This contamination could occur during manufacturing, especially in batches with specific NDC numbers.
Who’s affected
People who bought these ranitidine tablets from Wal-Mart stores in the US. Those taking the medication for acid-related issues are most at risk.
How to tell if you have this one
Check for NDC codes: Twin pack is 49035-100-07, single pack is 49035-100-00. These tablets were sold by Wal-Mart in the US with expiration dates still valid.
- Brand
Apotex- Category
Drug
All 6 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Completed- Distribution
Nationwide
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0314-2020 | Walgreens Maximum Strength Wal-Zan 150 Ranitidine Tablets, USP 150 mg/Acid Reducer Distributed By: Walgreen Co., 200 Wilmot RD., Deerfield, IL 60015 a) 200 Tablets NDC 0363-1030-07; b) 24 Tablets NDC 0363-1030-02; c) 95 Tablets NDC 0363-1030-09; d) 65 Tablets NDC 0363-1030-06; All lots remaining within expiry. | 259,647 bottles |
| D-0315-2020 | Walgreens Regular Strength Wal-Zan 75 Ranitidine Tablets, USP 75 mg/Acid Reducer 30 Tablets NDC 0363-1029-03 Distributed By: Walgreen Co., 200 Wilmot RD., Deerfield, IL 60015; All lots remaining within expiry. | 42,873 bottles |
| D-0316-2020 | Equate Maximum Strength Ranitidine Tablets, USP 150 mg Acid Reducer 130 Tablets Distributed by Wal-Mart Stores, Inc. Bentonville, AR 72716 a) Twin Pack NDC: 49035-100-07; b) Single Pack NDC: 49035-100-00; All lots remaining within expiry. | 1,132,453 bottles |
| D-0317-2020 | Rite Aid Pharmacy Maximum Strength Ranitidine Tablets, USP 150 mg Cool Mint Acid Reducer 24 Tablets Sugar Free NDC 11822-6107-4 Distributed By: Rite Aid 30 Hunter Lane, Camp Hill, PA 17011; All lots remaining within expiry. | 31,968 bottles |
| D-0318-2020 | Equate Maximum Strength Ranitidine Tablets, USP 150 mg Acid Reducer Cool Mint Tablets Sugar Free 65 Tablets NDC: 49035-117-06 Distributed By: Wal-Mart Stores, Inc. Bentonville, AR 72716; All lots remaining within expiry. | 162,344 bottles |
| D-0319-2020 | Rite Aid Pharmacy Maximum Strength Ranitidine Tablets, USP 150 mg-acid reducer Distributed By: Rite Aid 30 Hunter Lane Camp Hill, PA 17011 a) 50 tablets NDC 11822-6052-1; b) 65 tablets NDC 11822-6052-2; c) 95 tablets NDC 11822-4727-3; d) 24 tablets NDC 11822-6051-8; All lots remaining within expiry. | 215,387 bottles |
What to do — step by step
Check Product Details
Look for NDC codes 49035-100-07 (twin pack) or 49035-100-00 (single pack) on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 57 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0316-2020 (September 24, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0316-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.